126 related articles for article (PubMed ID: 32817984)
1. The operational impact of deploying SARS-CoV-2 vaccines in countries of the WHO African Region.
Ortiz JR; Robertson J; Hsu JS; Yu SL; Driscoll AJ; Williams SR; Chen WH; Fitzpatrick MC; Sow S; Biellik RJ; Okwo-Bele JM; Neuzil KM
medRxiv; 2020 Nov; ():. PubMed ID: 32817984
[TBL] [Abstract][Full Text] [Related]
2. The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.
Ortiz JR; Robertson J; Hsu JS; Yu SL; Driscoll AJ; Williams SR; Chen WH; Fitzpatrick MC; Sow S; Biellik RJ; Neuzil KM
Vaccine; 2021 Apr; 39(15):2165-2176. PubMed ID: 33744049
[TBL] [Abstract][Full Text] [Related]
3. The Operational Feasibility of Vaccination Programs Targeting Influenza Risk Groups in the World Health Organization (WHO) African and South-East Asian Regions.
Ortiz JR; Yu SL; Driscoll AJ; Williams SR; Robertson J; Hsu JS; Chen WH; Biellik RJ; Sow S; Kochhar S; Neuzil KM
Clin Infect Dis; 2022 Jan; 74(2):227-236. PubMed ID: 33949661
[TBL] [Abstract][Full Text] [Related]
4. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
Ho LL; Gurung S; Mirza I; Nicolas HD; Steulet C; Burman AL; Danovaro-Holliday MC; Sodha SV; Kretsinger K
Int J Infect Dis; 2022 Jun; 119():201-209. PubMed ID: 35398300
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of SARS-CoV-2 and influenza vaccines in healthcare workers: Results of two vaccination campaigns in a large teaching hospital in Rome.
Pascucci D; Lontano A; Regazzi L; Marziali E; Nurchis MC; Raponi M; Vetrugno G; Moscato U; Cadeddu C; Laurenti P
Hum Vaccin Immunother; 2023 Dec; 19(3):2287282. PubMed ID: 38016914
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
7. Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.
Moscara L; Venerito V; Martinelli A; Di Lorenzo A; Toro F; Violante F; Tafuri S; Stefanizzi P
Vaccine; 2023 Aug; 41(38):5655-5661. PubMed ID: 37544827
[TBL] [Abstract][Full Text] [Related]
8. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
[TBL] [Abstract][Full Text] [Related]
9. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
[TBL] [Abstract][Full Text] [Related]
10. Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on.
Mangat HS; Musah A; Luedtke S; Syed AA; Maramattom BV; Maruthanal J; Bosman A; Kostkova P
Front Public Health; 2022; 10():972464. PubMed ID: 36311588
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Omicron Variant: Exploring Healthcare Workers' Awareness and Perception of Vaccine Effectiveness: A National Survey During the First Week of WHO Variant Alert.
Temsah MH; Aljamaan F; Alenezi S; Alhasan K; Alrabiaah A; Assiri R; Bassrawi R; Alhaboob A; Alshahrani F; Alarabi M; Alaraj A; Alharbi NS; Halwani R; Jamal A; Al-Eyadhy A; AbdulMajeed N; Alfarra L; Almashdali W; Fayed A; Alzamil F; Barry M; Memish ZA; Al-Tawfiq JA; Alsubaie S
Front Public Health; 2022; 10():878159. PubMed ID: 35400032
[TBL] [Abstract][Full Text] [Related]
12. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
[TBL] [Abstract][Full Text] [Related]
13. Assessment of vaccination service delivery and quality: a cross-sectional survey of over 1300 health facilities from 29 districts in Sindh, Pakistan conducted between 2017-18.
Siddiqi DA; Abdullah S; Dharma VK; Khamisani T; Shah MT; Setayesh H; Khan AJ; Chandir S
BMC Health Serv Res; 2022 Jun; 22(1):727. PubMed ID: 35650570
[TBL] [Abstract][Full Text] [Related]
14. Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories.
Shet A; Carr K; Danovaro-Holliday MC; Sodha SV; Prosperi C; Wunderlich J; Wonodi C; Reynolds HW; Mirza I; Gacic-Dobo M; O'Brien KL; Lindstrand A
Lancet Glob Health; 2022 Feb; 10(2):e186-e194. PubMed ID: 34951973
[TBL] [Abstract][Full Text] [Related]
15. Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis.
Martin CA; Nazareth J; Jarkhi A; Pan D; Das M; Logan N; Scott S; Bryant L; Abeywickrama N; Adeoye O; Ahmed A; Asif A; Bandi S; George N; Gohar M; Gray LJ; Kaszuba R; Mangwani J; Martin M; Moorthy A; Renals V; Teece L; Vail D; Khunti K; Moss P; Tattersall A; Hallis B; Otter AD; Rowe C; Willett BJ; Haldar P; Cooper A; Pareek M
EClinicalMedicine; 2023 Apr; 58():101926. PubMed ID: 37034357
[TBL] [Abstract][Full Text] [Related]
16. Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic.
Banks C; Portnoy A; Moi F; Boonstoppel L; Brenzel L; Resch SC
Vaccine; 2021 Aug; 39(35):5046-5054. PubMed ID: 34325935
[TBL] [Abstract][Full Text] [Related]
17. Using a low-cost, real-time electronic immunization registry in Pakistan to demonstrate utility of data for immunization programs and evidence-based decision making to achieve SDG-3: Insights from analysis of Big Data on vaccines.
Siddiqi DA; Abdullah S; Dharma VK; Shah MT; Akhter MA; Habib A; Khan AJ; Chandir S
Int J Med Inform; 2021 May; 149():104413. PubMed ID: 33652259
[TBL] [Abstract][Full Text] [Related]
18. Severity of SARS-CoV-2 reinfection in vaccinated healthcare workers.
Golshahi F; Siami Z; Feizabad E; Rajabzadeh S; Zarinjooie S; Albaji M; Mabadi A; Azarnoush A; Nazemi P
Iran J Microbiol; 2023 Apr; 15(2):196-200. PubMed ID: 37193244
[TBL] [Abstract][Full Text] [Related]
19. Vaccination Utilization and Subnational Inequities during the COVID-19 Pandemic: An Interrupted Time-Series Analysis of Administrative Data across 12 Low- and Middle-Income Countries.
Mwinnyaa G; Peters MA; Shapira G; Neill R; Sadat H; Yuma S; Akilimali P; Hossain S; Wendrad N; Atiwoto WK; Ofosu AA; Alfred JP; Kiarie H; Wesseh CS; Isokpunwu C; Kangbai DM; Mohamed AA; Sidibe K; Drouard S; Fernandez PA; Azais V; Hashemi T; Hansen PM; Ahmed T
Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766092
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine.
Lombardi A; Renisi G; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Gori A; Bandera A
BMC Infect Dis; 2022 Jan; 22(1):97. PubMed ID: 35090388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
